Auto Refresh

Bharat Biotech Submits Clinical Trial Data of Covaxin in Children to CDSC

If approved, Covaxin will be the first COVID-19 vaccine that can be administered to children in India.

PTI

Last Updated: October 06, 2021, 07:20 IST

Hyderabad

Covid-19

Bharat Biotech, which completed the Phase 2/3 trials of COVID-19 vaccine Covaxin for use in children under 18 years of age, has submitted the data to the Central Drugs Standard Control Organisation for its verification and subsequent approval for Emergency Use Authorisation for the jab, company sources said on Wednesday. “Covaxin clinical trial data of 2-18 years age group has been submitted to CDSCO…This is feasible due to the Read More

Oct 06, 2021 21:50 IST

Covid Side Effect May Include Redness of Hands, Feet: Study

Redness and inflammation in the hands and feet, referred to as COVID toe condition, may be one of the side effects of COVID-19, a new study published in the British Journal of Dermatology’ has noted.

Oct 06, 2021 21:16 IST

Mumbai Logs Over 600 COVID-19 Cases in Day After July 14; Seven Die

For the first time after July 14, Mumbai on Wednesday logged more than 600 new COVID-19 cases a day ahead of the scheduled reopening of temples and other religious places in Maharashtra on the first day of the Navratri festival.

Oct 06, 2021 19:13 IST

Delhi reports 26 Covid cases, zero deaths

Oct 06, 2021 17:51 IST

Single-dose Sputnik Light Vaccine Authorized In UAE

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) today announced the Russian single-component Sputnik Light vaccine against coronavirus has been approved by the Ministry of Health and Prevention (MOHAP) of UAE. Sputnik Light vaccine is based on human adenovirus serotype 26 which is the first component of the Sputnik V vaccine. The single-dose vaccine has also been approved in UAE as a booster shot.

Oct 06, 2021 17:15 IST

Covid Vaccine Hesitancy in India at Lowest Level, Only 7% Adults Now Hesitant: Survey

Only 7 per cent Indian adults are currently hesitant to getting inoculated against COVID-19, the lowest vaccine hesitancy level in the country so far, according to a new survey. The study conducted by the online community platform LocalCircles received 12,810 responses from citizens — 67 per cent men and 33 per cent women — across 301 districts.

Oct 06, 2021 16:29 IST

Andhra Pradesh Reports 800 Covid Cases

Andhra Pradesh reports 800 fresh Covid cases, 1,178 recoveries, and 09 deaths in the past 24 hours. Active cases: 8,754 Total recoveries: 20,31,681 Death toll: 14,228. 

Oct 06, 2021 16:18 IST

WHO Says Number of New Covid Cases Fell Last Week

The World Health Organization says the number of newly reported coronavirus cases fell in the last week, continuing a declining global trend that first began in August. In its latest assessment of the pandemic, the U.N. health agency reported Tuesday that there were 3.1 million new COVID-19 cases, a 9% fall, and about 54,000 deaths in the last week, roughly similar to the week before. WHO said there were declines in case numbers in all world regions except for Europe, where the number was about the same as the previous week.

Oct 06, 2021 16:06 IST

Coronavirus Deaths in Russia Surpass 900 a Day for 1st Time

Russia’s daily toll of coronavirus deaths surpassed 900 for the first time of the pandemic Wednesday, a record that comes amid the country’s low vaccination rate and the government’s reluctance to impose tough restrictions to control new cases.

Oct 06, 2021 13:07 IST

Maharashtra's Ahmednagar Records 10 Deaths in 24 Hours, Restrictions in 61 Villages

Maharashtra recorded 2401 new Covid-19 cases and 39 deaths in the last 24 hours. And of the 39 deaths, 10 were recorded in Ahmed Nagar alone, pushing  the Maharashtra government to be on its toes once again. The state has taken control of the situation as the cases fell drastically in the past few weeks. But tensions are once again high as Ahmednagar recorded somewhere between 400-500 infections in the last 24 hours.

Oct 06, 2021 12:16 IST

India May Need Booster Shots Post Covid-19 Vaccination But Need is Not Immediate, Urgent: Top CSIR Scientist

India may eventually need booster shots post Covid-19 vaccination but the need is not immediate or urgent, Dr Anurag Agrawal, director, Institute of Genomics and Integrative Biology (IGIB), told News18.com. According to Dr Agrawal, Covid infection plus vaccine shots are expected to give immunity as strong or may be better than two shots plus booster.

Oct 06, 2021 10:52 IST

26 people including 5 school students tested Covid positive in Oct in Gujarat

Oct 06, 2021 10:00 IST

SII Expands Covovax Paediatric Trial, Aims To Include Kids Aged 2-6

Explaining the workings of the trial phase, a trial investigator told TOI that the trial is expanded after ensuring the vaccine safety in 100 children from each group in the reverse order of age. The Serum Institute of India (SII), partnering with Novavax, is expected to launch Covovax for adults in India by November this year and for children early next year. READ MORE 

Oct 06, 2021 09:28 IST

India Reported 18,833 New Cases in the Last 24 Hrs

 India reports 18,833 new cases in the last 24 hours. Active caseload stands at 2,46,687, the lowest in 203 days, as per Ministry of Health and Family Welfare
Oct 06, 2021 09:06 IST

Temples Reopen, Garba Banned, No Durga Carnival: Know Your State's Covid SOPs as India Set for Navratri

Among other temples, Mumbai’s Siddhivinayak temple will also reopen tomorrow for devotees. The nine-day-long Navratri festival which begins on October 7. All devotees will be allowed only through pre-booking QR codes on Temple Trust’s app. Only 250 devotees to be issued QR codes every hour for darshan, the temple trust informed. The visitors will have to follow the Covid 19 protocol. READ MORE 

Oct 06, 2021 08:34 IST

‘Pfizer vax provides 90% protection against hospitalisation for 6 months’

The Pfizer-BioNTech Covid vaccine is 90% effective at preventing hospitalisation for up to six months, with no signs of waning during that time period, according to a large new US study conducted by researchers at Pfizer and Kaiser Permanente. The vaccine also provides powerful protection against the highly contagious Delta variant, the scientists found.

Oct 06, 2021 08:12 IST

Siddhivinayak Temple To Reopen Tomorrow For Devotees

Oct 06, 2021 07:50 IST

Kolkata Metro Services To Ply Till 11pm Amid Festive Season

Oct 06, 2021 07:43 IST

WHO to Finalise Nod to Covaxin Next Week, Health Body Currently ‘Reviewing Additional Data’

The World Health Organisation on Tuesday said a decision on the Emergency Use Listing (EUL) of India’s home-grown coronavirus vaccine, Covaxin, will be finalised next week when the health watchdog and an independent group of experts will meet to carry out an assessment of the risks and benefits of the jab.

Oct 06, 2021 07:32 IST

Anganwadi Workers to Get PMGKY Health Cover of Rs 50 Lakh on Covid-19 Duty

The central government has decided that Anganwadi workers would also be covered under the insurance scheme of Pradhan Mantri Garib Kalyan Yojana with an insurance cover of Rs 50 lakh. As per the information available with the Ministry of Women and Child Development, the nodal ministry for Anganwadi workers, there are 13,00,029 Anganwadi workers and 11,79000 Anganwadi helpers and those who aided with Covid-19 related duties will be brought under the insurance cover. READ MORE 

Oct 06, 2021 07:26 IST

Durga Puja Organizers Cut Short Budget to Support Covid Orphans

As per government data in Bengal, there are 308 recorded orphans whose both parents had died of Covid-19 till August 26, two of whom were abandoned and are now growing up in a government-sponsored home. There are 6,270 more children whose father or mother has died of the infection during this period.

safety of the manufacturing platform and empirical evidence from Phase 1,2 and 3 clinical trials in adults,” sources told PTI.

Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella, had said on September 21 that the Paediatric Covaxin completed phase 2/3 trials with about 1,000 subjects and the data analysis was going on. As part of the Phase II/III trial, the two-dose Covaxin was administered with 28 days apart.

“We will be submitting the data (to the regulator) by next week,” he had said. He also had said that Phase 2 trials of intranasal vaccine to prevent COVID-19 were going on and expected to be over in October.

If approved, Covaxin will be the first COVID-19 vaccine that can be administered to children in India.

Read all the Latest News, Breaking News and Coronavirus News here. Follow us on Facebook, Twitter and Telegram.